Impact of the COVID-19 pandemic on the incidence and mortality of hospital-onset bloodstream infection: a cohort study

被引:6
|
作者
Valik, John Karlsson [1 ,2 ]
Hedberg, Pontus [3 ]
Holmberg, Fredrik [1 ]
van der Werff, Suzanne Desiree [1 ]
Naucler, Pontus [1 ,2 ]
机构
[1] Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
[3] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
关键词
COVID-19; adverse events; epidemiology and detection; infection control; nosocomial infections; healthcare quality improvement; BACTEREMIA; FUNGEMIA;
D O I
10.1136/bmjqs-2021-014243
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The COVID-19 pandemic burdens hospitals, but consequences for quality of care outcomes such as healthcare-associated infections are largely unknown. This cohort included all adult hospital episodes (n=186 945) at an academic centre between January 2018 and January 2021. Data were collected from the hospitals' electronic health record data repository. Hospital-onset bloodstream infection (HOB) was defined as any positive blood culture obtained >= 48 hours after admission classified based on microbiological and hospital administrative data. Subgroup analyses were performed with exclusion of potential contaminant bacteria. The cohort was divided into three groups: controls (prepandemic period), non-COVID-19 (pandemic period) and COVID-19 (pandemic period) based on either PCR-confirmed SARS-CoV-2 infections from respiratory samples or International Classification of Diseases 10th Revision diagnoses U071 and U72 at discharge. Adjusted incidence rate ratios (aIRR) and risk of death in patients with HOB were compared between the prepandemic and pandemic periods using Poisson and logistic regression. The incidence of HOB was increased for the COVID-19 group compared with the prepandemic period (aIRR 3.34, 95% CI 2.97 to 3.75). In the non-COVID-19 group, the incidence was slightly increased compared with prepandemic levels (aIRR 1.20, 95% CI 1.08 to 1.32), but the difference decreased when excluding potential contaminant bacteria (aIRR 1.15, 95% CI 1.00 to 1.31, p=0.04). The risk of dying increased for both the COVID-19 group (adjusted odds ratio (aOR) 2.44, 95% CI 1.75 to 3.38) and the non-COVID-19 group (aOR 1.63, 95% CI 1.22 to 2.16) compared with the prepandemic controls. These findings were consistent also when excluding potential contaminants. In summary, we observed a higher incidence of HOB during the COVID-19 pandemic, and the mortality risk associated with HOB was greater, compared with the prepandemic period. Results call for specific attention to quality of care during the pandemic.
引用
收藏
页码:379 / 382
页数:4
相关论文
共 50 条
  • [1] Hospital-onset COVID-19 and antivirals
    Khan, G. H.
    Jeilani, M.
    Bryant, S.
    Butler, C.
    Iossifidis, E.
    Sleiman, S.
    Moosavi, S. H.
    Shoaib, J.
    Szeto, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Hospital-onset Clostridioides difficile infections during the COVID-19 pandemic
    Luo, Yuying
    Grinspan, Lauren T.
    Fu, Yichun
    Adams-Sommer, Victoria
    Willey, D. Kyle
    Patel, Gopi
    Grinspan, Ari M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (09): : 1165 - 1166
  • [3] Hospital-onset COVID-19 infection surveillance systems: a systematic review
    Abbas, M.
    Zhu, N. J.
    Mookerjee, S.
    Bolt, F.
    Otter, J. A.
    Holmes, A. H.
    Price, J. R.
    JOURNAL OF HOSPITAL INFECTION, 2021, 115 : 44 - 50
  • [4] Impact of COVID-19 pandemic on hospital onset bloodstream infections (HOBSI) at a large health system
    Sturm, Lisa K.
    Saake, Karl
    Roberts, Phil B.
    Masoudi, Frederick A.
    Fakih, Mohamad G.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2022, 50 (03) : 245 - 249
  • [5] Evaluation of clinical harm associated with Omicron hospital-onset COVID-19 infection
    Otter, Jonathan A.
    Newsholme, William
    Snell, Luke B.
    Merrick, Blair
    Okeke, Nneoma
    Mack, Damien J. F.
    Breathnach, Aodhan S.
    Price, Nicholas M.
    JOURNAL OF INFECTION, 2023, 86 (01) : 79 - 80
  • [6] Impact of the COVID-19 pandemic on cancer incidence and mortality
    Wells, Chad R.
    Gaivani, Alison P.
    LANCET PUBLIC HEALTH, 2022, 7 (06): : E490 - E491
  • [7] COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease
    Simon E. Brill
    Hannah C. Jarvis
    Ezgi Ozcan
    Thomas L. P. Burns
    Rabia A. Warraich
    Lisa J. Amani
    Amina Jaffer
    Stephanie Paget
    Anand Sivaramakrishnan
    Dean D. Creer
    BMC Medicine, 18
  • [8] COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease
    Brill, Simon E.
    Jarvis, Hannah C.
    Ozcan, Ezgi
    Burns, Thomas L. P.
    Warraich, Rabia A.
    Amani, Lisa J.
    Jaffer, Amina
    Paget, Stephanie
    Sivaramakrishnan, Anand
    Creer, Dean D.
    BMC MEDICINE, 2020, 18 (01)
  • [9] Population and hospital-level COVID-19 measures are associated with increased risk of hospital-onset COVID-19
    Schmitz, Emily
    Anderson, Laura
    Hatas, Gabrielle
    Stevens, Linda
    Osman, Fauzia
    Schweizer, Marin
    Safdar, Nasia
    Shirley, Daniel
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2024, 45 (08) : 1009 - 1011
  • [10] Impact of the COVID-19 pandemic on the incidence and the epidemiology of catheter-related bloodstream infection two years later
    Perez-Granda, Maria Jesus
    Burillo, Almudena
    Serrano-Lobo, Julia
    Martin-Rabadan, Pablo
    Munoz, Patricia
    Bouza, Emilio
    Guembe, Maria
    HELIYON, 2024, 10 (14)